Updates from The Motley Fool

Latest updates on Valeant Pharmaceuticals from Fool.com.

Stock Performance

VRX vs. S&P 500 | 2 Year Performance
VRX 1-Day Stock Chart
VRX 5-Day Stock Chart
VRX 1-Month Stock Chart
VRX 3-Month Stock Chart
VRX 6-Month Stock Chart
VRX 1-Year Stock Chart
VRX 2-Year Stock Chart
VRX 5-Year Stock Chart
View Interactive VRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Valeant Pharmaceuticals.
Current Price: $26.94
Prev Close: $27.12
Open: $27.23
Bid: $26.95
Ask: $26.99
Day's Range: $26.36 - $27.36
52wk Range: $23.55 - $263.81
Volume: 13,893,636
Avg Vol 31,898,042
Market Cap: $9.24B
P/E (ttm): -31.91
EPS (ttm): -$0.85
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Valeant Pharmaceuticals.
CAPS Rating 2 out of 5
512 Outperform
89 Underperform
CAPS All Stars
119 Outperform
34 Underperform

How do you think Valeant Pharmaceuticals will perform against the market?

You pick for Valeant Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

J. Michael Pearson, CEO

21% Approve

Based on 67 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Valeant Pharmaceuticals.

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers